BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3979939)

  • 1. [Mitoxantrone--a new cytostatic agent].
    Klein HO
    Fortschr Med; 1985 Feb; 103(8):229-30. PubMed ID: 3979939
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone: a promising new chemotherapeutic agent.
    Dalton WS; Alberts DS
    Ariz Med; 1984 Feb; 41(2):96-8. PubMed ID: 6703919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of mitoxantrone].
    Tada A; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Ikeda K; Adachi K; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1649-54. PubMed ID: 6476838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of mitoxantrone in the treatment of tumors].
    Klener P
    Cas Lek Cesk; 1984 Jul; 123(28):873. PubMed ID: 6488260
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineoplastic spectrum of mitoxantrone in rat ascitic hepatoma].
    Satoh H
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):26-30. PubMed ID: 7184361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone: a new anticancer drug with significant clinical activity.
    Shenkenberg TD; Von Hoff DD
    Ann Intern Med; 1986 Jul; 105(1):67-81. PubMed ID: 3521429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone in patients with acute leukemia in relapse.
    Paciucci PA; Ohnuma T; Cuttner J; Silver RT; Holland JF
    Cancer Res; 1983 Aug; 43(8):3919-22. PubMed ID: 6861154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study.
    Levin M; Pandya KJ; Khandekar JD; Horton J; Glick JH; Bennett JM; Muggia FM; Falkson G
    Cancer Treat Rep; 1984 Dec; 68(12):1511-2. PubMed ID: 6509455
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitoxantrone in the treatment of relapsed and refractory acute leukemia.
    Ehninger G; Ho AD; Meyer P; Mjaaland I; Ostendorf P; Seither E
    Onkologie; 1985 Jun; 8(3):146-8. PubMed ID: 3895096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone (novantrone): a review of experimental and early clinical studies.
    Smith IE
    Cancer Treat Rev; 1983 Jun; 10(2):103-15. PubMed ID: 6347376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical pharmacology of mitoxantrone].
    Robak T; Drzewoski J
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1473-5. PubMed ID: 3913945
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of mitoxantrone for acute leukemia].
    Oguma S; Tatsumi Y; Hirayama F; Tani Y; Kubota Y; Kanakura Y; Ueda T; Nakamura H; Shibata H; Masaoka T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):497-501. PubMed ID: 6703723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papers presented at a symposium on cancer chemotherapy in the 1980's. Monte Carlo, 11th-12th October, 1984.
    Invest New Drugs; 1985; 3(2):79-222. PubMed ID: 3894281
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitoxantrone in relapsed and refractory acute leukemia.
    Prentice HG; Robbins G; Ma DD; Ho AD
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):32-5. PubMed ID: 6385263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytostatic agents and cytostatic therapy].
    Host H
    Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1857-62. PubMed ID: 4767918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.